HOPX and nasopharyngeal carcinoma: The results indicated that 111 of 188 (59.0%) NPC patients in the validation cohort had representatively high HOPX methylation levels, and patients with high HOPX methylation also had shorter DMFS, OS and DFS (Fig. 10d–f).